These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21315174)

  • 21. Protein-based profiling of the immune response to uropathogenic Escherichia coli in adult patients immediately following hospital admission for acute cystitis.
    Sundac L; Dando SJ; Sullivan MJ; Derrington P; Gerrard J; Ulett GC
    Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27354295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmentation of Urinary Lactoferrin Enhances Host Innate Immune Clearance of Uropathogenic Escherichia coli.
    Patras KA; Ha AD; Rooholfada E; Olson J; Ramachandra Rao SP; Lin AE; Nizet V
    J Innate Immun; 2019; 11(6):481-495. PubMed ID: 31055580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ceftibuten-induced filamentation of extended spectrum beta lactamase (ESBL)-producing uropathogenic Escherichia coli alters host cell responses during an in vitro infection.
    Demirel I; Kruse R; Önnberg A; Persson K
    Microb Pathog; 2015 Jan; 78():52-62. PubMed ID: 25433242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli.
    Hunstad DA; Justice SS
    Annu Rev Microbiol; 2010; 64():203-21. PubMed ID: 20825346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection.
    Duell BL; Carey AJ; Tan CK; Cui X; Webb RI; Totsika M; Schembri MA; Derrington P; Irving-Rodgers H; Brooks AJ; Cripps AW; Crowley M; Ulett GC
    J Immunol; 2012 Jan; 188(2):781-92. PubMed ID: 22184725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection.
    Ulett GC; Totsika M; Schaale K; Carey AJ; Sweet MJ; Schembri MA
    Curr Opin Microbiol; 2013 Feb; 16(1):100-7. PubMed ID: 23403118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virulence genes and phylogenetic groups of uropathogenic Escherichia coli isolates from patients with urinary tract infection and uninfected control subjects: a case-control study.
    Rezatofighi SE; Mirzarazi M; Salehi M
    BMC Infect Dis; 2021 Apr; 21(1):361. PubMed ID: 33865334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.
    Nagamatsu K; Hannan TJ; Guest RL; Kostakioti M; Hadjifrangiskou M; Binkley J; Dodson K; Raivio TL; Hultgren SJ
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E871-80. PubMed ID: 25675528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of type 1 piliation on chemotaxis and intracellular killing of uropathogenic E. coli by human polymorphonuclear leukocyts.
    Peerayeh SN; Nooritalab N; Moazeni M; Sattari M
    Pak J Biol Sci; 2007 Aug; 10(15):2599-602. PubMed ID: 19070139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection.
    Lin AE; Beasley FC; Olson J; Keller N; Shalwitz RA; Hannan TJ; Hultgren SJ; Nizet V
    PLoS Pathog; 2015 Apr; 11(4):e1004818. PubMed ID: 25927232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis.
    Davis JM; Carvalho HM; Rasmussen SB; O'Brien AD
    Infect Immun; 2006 Aug; 74(8):4401-8. PubMed ID: 16861625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virulence behavior of uropathogenic Escherichia coli strains in the host model Caenorhabditis elegans.
    Schifano E; Marazzato M; Ammendolia MG; Zanni E; Ricci M; Comanducci A; Goldoni P; Conte MP; Uccelletti D; Longhi C
    Microbiologyopen; 2019 Jun; 8(6):e00756. PubMed ID: 30381890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Gene Expression Profile of Uropathogenic Escherichia coli in Women with Uncomplicated Urinary Tract Infections Is Recapitulated in the Mouse Model.
    Frick-Cheng AE; Sintsova A; Smith SN; Krauthammer M; Eaton KA; Mobley HLT
    mBio; 2020 Aug; 11(4):. PubMed ID: 32788379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis.
    Nicholson TF; Watts KM; Hunstad DA
    Infect Immun; 2009 Dec; 77(12):5245-51. PubMed ID: 19797074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M; Asadi Karam MR; Bouzari S
    APMIS; 2016 Jun; 124(6):444-52. PubMed ID: 26918627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flagellin/TLR5 signalling activates renal collecting duct cells and facilitates invasion and cellular translocation of uropathogenic Escherichia coli.
    Bens M; Vimont S; Ben Mkaddem S; Chassin C; Goujon JM; Balloy V; Chignard M; Werts C; Vandewalle A
    Cell Microbiol; 2014 Oct; 16(10):1503-17. PubMed ID: 24779433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia.
    Dadi BR; Abebe T; Zhang L; Mihret A; Abebe W; Amogne W
    BMC Infect Dis; 2020 Feb; 20(1):108. PubMed ID: 32033541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blocking yersiniabactin import attenuates extraintestinal pathogenic Escherichia coli in cystitis and pyelonephritis and represents a novel target to prevent urinary tract infection.
    Brumbaugh AR; Smith SN; Subashchandrabose S; Himpsl SD; Hazen TH; Rasko DA; Mobley HL
    Infect Immun; 2015 Apr; 83(4):1443-50. PubMed ID: 25624354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The UbiI (VisC) Aerobic Ubiquinone Synthase Is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli.
    Floyd KA; Mitchell CA; Eberly AR; Colling SJ; Zhang EW; DePas W; Chapman MR; Conover M; Rogers BR; Hultgren SJ; Hadjifrangiskou M
    J Bacteriol; 2016 Oct; 198(19):2662-72. PubMed ID: 27161114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptation of Arginine Synthesis among Uropathogenic Branches of the Escherichia coli Phylogeny Reveals Adjustment to the Urinary Tract Habitat.
    Hibbing ME; Dodson KW; Kalas V; Chen SL; Hultgren SJ
    mBio; 2020 Sep; 11(5):. PubMed ID: 32994329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.